{"id":"W2120393706","doi":"10.1136/annrheumdis-2016-210715","title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","year":2017,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":5775,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"European League Against Rheumatism; National Institute for Health and Care Research","keywords":"Medicine; Abatacept; Adalimumab; Certolizumab pegol; Tocilizumab; Infliximab; Golimumab; Etanercept; Rituximab; Rheumatoid arthritis; Antirheumatic drugs; Rheumatism; Antirheumatic Agents; Intensive care medicine; Disease; Physical therapy; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003637386,0.001467211,0.003620218,0.004942582,0.0003957026,0.001973383,0.002523853,0.002578605,0.008533294],"category_scores_gemma":[0.00662182,0.0005493812,0.002819172,0.003377462,0.000556525,0.001962931,0.001399526,0.003061617,0.00378968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001614895,"about_ca_system_score_gemma":0.006439118,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004802372,"about_ca_topic_score_gemma":0.01142183,"domain_scores_codex":[0.9981954,0.0003867084,0.0005717115,0.0001048947,0.0006417579,0.00009950349],"domain_scores_gemma":[0.9970893,0.001043799,0.000718746,0.00004513553,0.0009576041,0.0001454727],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003472662,0.0001233761,0.0002640676,0.07334737,0.0005006015,0.0001559106,0.00008268371,0.000279542,0.0006073374,0.002251346,0.1646844,0.7573561],"study_design_scores_gemma":[0.0003188491,0.0001169757,0.00127877,0.0672925,0.001394607,0.0005080099,0.00008394376,0.00007917481,0.0001694285,0.001498827,0.9272166,0.00004243017],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008520226,0.9943634,0.0002358753,0.002364773,0.001092612,0.00005676982,0.0003207475,0.0000238953,0.001456653],"genre_scores_gemma":[0.0004125332,0.9946553,0.0009348603,0.002313249,0.0003396023,0.00006070621,0.0004253789,0.000006345979,0.0008520504],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008533294,"threshold_uncertainty_score":0.02854675,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1403382247591931,"score_gpt":0.3964591459019126,"score_spread":0.2561209211427196,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}